info: ARRY BOULDER, Colo. (AP) _ Array BioPharma
Post# of 658
![](/assets/46931549/no_avatar_available_thumb.jpg)
Quote:
BOULDER, Colo. (AP) _ Array BioPharma Inc. (ARRY) on Tuesday reported a loss of $28.6 million in its fiscal first quarter.
On a per-share basis, the Boulder, Colorado-based company said it had a loss of 20 cents.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The drug developer posted revenue of $39.3 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $37.2 million.
Array BioPharma shares have climbed 35 percent since the beginning of the year. The stock has climbed 11 percent in the last 12 months.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone